Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial. New ...

MorphoSys has said it will press ahead with regulatory filings for its myelofibrosis drug candidate pelabresib, despite mixed results in a phase 3 trial. The German biotech says it hopes the totality ...

Tucked away in Seaford, Delaware sits a secondhand shopping haven that’s become the stuff of legend among bargain hunters – the Delmarva Teen Challenge Mega Thrift Store. This isn’t just another dusty ...